A Photoinitiator-Free Bioink Platform: Tyrosine-Assisted UV Crosslinking of Decellularized Extracellular Matrix/Zein Scaffolds Optimized by Full Factorial Design

IF 3.9 3区 医学 Q2 ENGINEERING, BIOMEDICAL
Banuay Coşkun, Özlem Biçen Ünlüer
{"title":"A Photoinitiator-Free Bioink Platform: Tyrosine-Assisted UV Crosslinking of Decellularized Extracellular Matrix/Zein Scaffolds Optimized by Full Factorial Design","authors":"Banuay Coşkun,&nbsp;Özlem Biçen Ünlüer","doi":"10.1002/jbma.70034","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>The clinical translation of 3D-bioprinted tissues is significantly limited by the cytotoxicity of synthetic photoinitiators used in photopolymerizable bioinks. To address this critical challenge, we developed a novel, fully photoinitiator-free bioink platform based on methacrylated decellularized extracellular matrix (dECM-MA) and a biomacromolecular crosslinker zein (BMC-Z). The key innovation of this work is the exploitation of the innate UV reactivity of tyrosine residues naturally abundant in dECM, which function as an intrinsic photoinitiator system. BMC-Z plays a dual role, simultaneously providing immediate rheological stability through a hydrophobic physical network and enhancing the tyrosine-mediated radical generation for covalent photocrosslinking. A Full Factorial Design (FFD) was employed to efficiently optimize the complex interactions between dECM-MA, hyaluronic acid (HA), hydroxyapatite (HAp), and BMC-Z. The optimal formulation (40 mg/mL dECM-MA, 2 mg/mL HA, 3 mg/mL HAp, 160 μL BMC-Z) exhibited excellent viscoelastic properties (tan δ = 0.286) and significantly enhanced storage modulus (G′). Remarkably, this bioink supported outstanding biological performance, demonstrating 95% ± 3% cell viability over 14 days and a 4.8-fold increase in cell proliferation (4.16 × 10<sup>5</sup> → 2.0 × 10<sup>6</sup> cells/scaffold). This study introduces a paradigm-shifting, non-toxic, and high-performance bioink strategy that effectively eliminates the dependency on exogenous photoinitiators, paving the way for safer and more clinically relevant tissue engineering applications.</p>\n </div>","PeriodicalId":15142,"journal":{"name":"Journal of biomedical materials research. Part A","volume":"114 2","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part A","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbma.70034","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

The clinical translation of 3D-bioprinted tissues is significantly limited by the cytotoxicity of synthetic photoinitiators used in photopolymerizable bioinks. To address this critical challenge, we developed a novel, fully photoinitiator-free bioink platform based on methacrylated decellularized extracellular matrix (dECM-MA) and a biomacromolecular crosslinker zein (BMC-Z). The key innovation of this work is the exploitation of the innate UV reactivity of tyrosine residues naturally abundant in dECM, which function as an intrinsic photoinitiator system. BMC-Z plays a dual role, simultaneously providing immediate rheological stability through a hydrophobic physical network and enhancing the tyrosine-mediated radical generation for covalent photocrosslinking. A Full Factorial Design (FFD) was employed to efficiently optimize the complex interactions between dECM-MA, hyaluronic acid (HA), hydroxyapatite (HAp), and BMC-Z. The optimal formulation (40 mg/mL dECM-MA, 2 mg/mL HA, 3 mg/mL HAp, 160 μL BMC-Z) exhibited excellent viscoelastic properties (tan δ = 0.286) and significantly enhanced storage modulus (G′). Remarkably, this bioink supported outstanding biological performance, demonstrating 95% ± 3% cell viability over 14 days and a 4.8-fold increase in cell proliferation (4.16 × 105 → 2.0 × 106 cells/scaffold). This study introduces a paradigm-shifting, non-toxic, and high-performance bioink strategy that effectively eliminates the dependency on exogenous photoinitiators, paving the way for safer and more clinically relevant tissue engineering applications.

无光引发剂的生物连接平台:酪氨酸辅助紫外交联脱细胞细胞外基质/玉米蛋白支架的全因子设计优化。
3d生物打印组织的临床翻译受到用于光聚合生物墨水的合成光引发剂的细胞毒性的显著限制。为了解决这一关键挑战,我们开发了一种基于甲基丙烯酸脱细胞细胞外基质(dECM-MA)和生物大分子交联剂玉米蛋白(BMC-Z)的新型、完全无光引发剂的生物连接平台。这项工作的关键创新是利用了dECM中天然丰富的酪氨酸残基的固有紫外反应性,它是一种内在的光引发剂系统。BMC-Z具有双重作用,同时通过疏水物理网络提供即时流变稳定性,并增强酪氨酸介导的共价光交联自由基的生成。采用全因子设计(FFD)有效优化dECM-MA、透明质酸(HA)、羟基磷灰石(HAp)和BMC-Z之间的复杂相互作用。最佳配方(40 mg/mL dECM-MA、2 mg/mL HA、3 mg/mL HAp、160 μL BMC-Z)具有良好的粘弹性(tan δ = 0.286)和显著提高的贮藏模量(G′)。值得注意的是,该生物链接具有出色的生物学性能,在14天内细胞存活率为95%±3%,细胞增殖率提高4.8倍(4.16 × 105→2.0 × 106细胞/支架)。本研究介绍了一种范式转换、无毒、高性能的生物链接策略,有效地消除了对外源性光引发剂的依赖,为更安全、更临床相关的组织工程应用铺平了道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of biomedical materials research. Part A
Journal of biomedical materials research. Part A 工程技术-材料科学:生物材料
CiteScore
10.40
自引率
2.00%
发文量
135
审稿时长
3.6 months
期刊介绍: The Journal of Biomedical Materials Research Part A is an international, interdisciplinary, English-language publication of original contributions concerning studies of the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. The Journal publishes peer-reviewed articles on all relevant biomaterial topics including the science and technology of alloys,polymers, ceramics, and reprocessed animal and human tissues in surgery,dentistry, artificial organs, and other medical devices. The Journal also publishes articles in interdisciplinary areas such as tissue engineering and controlled release technology where biomaterials play a significant role in the performance of the medical device. The Journal of Biomedical Materials Research is the official journal of the Society for Biomaterials (USA), the Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials. Articles are welcomed from all scientists. Membership in the Society for Biomaterials is not a prerequisite for submission.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书